🇺🇸 FDA
Patent

US 8686010

Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors

granted A61KA61K31/40A61K31/415

Quick answer

US patent 8686010 (Aryl- or heteroaryl-sulfonyl compounds as acid secretion inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/40, A61K31/415, A61K31/417, A61K31/4178